163 related articles for article (PubMed ID: 24510792)
1. Isolation of human melanoma stem cells using ALDH as a marker.
Luo Y; Nguyen N; Fujita M
Curr Protoc Stem Cell Biol; 2013 Sep; 26():3.8.1-3.8.10. PubMed ID: 24510792
[TBL] [Abstract][Full Text] [Related]
2. Culture and isolation of melanoma-initiating cells.
Stecca B; Santini R; Pandolfi S; Penachioni JY
Curr Protoc Stem Cell Biol; 2013 Feb; Chapter 3():Unit 3.6. PubMed ID: 23404674
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma.
Prasmickaite L; Engesaeter BØ; Skrbo N; Hellenes T; Kristian A; Oliver NK; Suo Z; Maelandsmo GM
PLoS One; 2010 May; 5(5):e10731. PubMed ID: 20505780
[TBL] [Abstract][Full Text] [Related]
5. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.
Lin JJ; Huang CS; Yu J; Liao GS; Lien HC; Hung JT; Lin RJ; Chou FP; Yeh KT; Yu AL
Breast Cancer Res; 2014 Mar; 16(2):R29. PubMed ID: 24670249
[TBL] [Abstract][Full Text] [Related]
6. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.
Clay MR; Tabor M; Owen JH; Carey TE; Bradford CR; Wolf GT; Wicha MS; Prince ME
Head Neck; 2010 Sep; 32(9):1195-201. PubMed ID: 20073073
[TBL] [Abstract][Full Text] [Related]
7. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
[TBL] [Abstract][Full Text] [Related]
9. Selection of tumorigenic melanoma cells using ALDH.
Boonyaratanakornkit JB; Yue L; Strachan LR; Scalapino KJ; LeBoit PE; Lu Y; Leong SP; Smith JE; Ghadially R
J Invest Dermatol; 2010 Dec; 130(12):2799-808. PubMed ID: 20739950
[TBL] [Abstract][Full Text] [Related]
10. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
[TBL] [Abstract][Full Text] [Related]
11. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
12. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
Zhang S; Yang Z; Qi F
Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma.
Zou B; Sun S; Qi X; Ji P
Mol Med Rep; 2012 Apr; 5(4):1116-20. PubMed ID: 22307065
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics.
Doherty RE; Sisley K; Hammond DW; Rennie IG; Cross NA
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5387-5395. PubMed ID: 29049740
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
17. ALDH as a marker for enriching tumorigenic human colonic stem cells.
Shenoy A; Butterworth E; Huang EH
Methods Mol Biol; 2012; 916():373-85. PubMed ID: 22914954
[TBL] [Abstract][Full Text] [Related]
18. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Ginestier C; Hur MH; Charafe-Jauffret E; Monville F; Dutcher J; Brown M; Jacquemier J; Viens P; Kleer CG; Liu S; Schott A; Hayes D; Birnbaum D; Wicha MS; Dontu G
Cell Stem Cell; 2007 Nov; 1(5):555-67. PubMed ID: 18371393
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase activity as a functional marker for lung cancer.
Ucar D; Cogle CR; Zucali JR; Ostmark B; Scott EW; Zori R; Gray BA; Moreb JS
Chem Biol Interact; 2009 Mar; 178(1-3):48-55. PubMed ID: 18952074
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
